Analytical Data
-
Gene name
DCDC1
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P59894
-
Expression Region
Met1~Arg213
-
Molecular Weight
27kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DCDC1, or Doublecortin Domain Containing 1, is a protein that plays a crucial role in neuronal development and function. Initially identified in the context of brain development, DCDC1 is characterized by the presence of doublecortin domains, which are implicated in microtubule binding and stability, crucial for neuronal migration and morphology. Research has increasingly highlighted its involvement in disorders related to neuronal dysfunction, as variations in the DCDC1 gene have been associated with conditions such as dyslexia and other cognitive impairments. The study of recombinant DCDC1 protein serves to elucidate its structural and functional properties, enabling researchers to investigate the molecular mechanisms underlying its role in neurodevelopmental processes. Furthermore, understanding DCDC1’s interactions with cytoskeletal elements can provide insights into how defects in this protein contribute to neurological disorders. The recombinant production of DCDC1 facilitates the exploration of its potential as a therapeutic target, as well as its use in model systems to study neuronal dynamics and migration. Overall, ongoing research into DCDC1 is essential for developing a comprehensive understanding of its biological significance, and it may ultimately lead to advancements in treating neurodevelopmental disorders linked to its dysfunction.
